Is OEM or ODM service available?

Yes, we offer OEM/ODM options with multiple packaging formats, regulatory document support, and scalable order volumes.

What is the shelf life of the product?

The product has a shelf life of 18 months when stored correctly.

Rveiling® Dca-Containing Lipolysis Injection Solution

Name: Rveiling® Dca-Containing Lipolysis Injection Solution
Brand: Hangzhou Yanfeng Technology Co., Ltd.
SKU: 2136809972

Zhejiang, ChinaHangzhou Yanfeng Technology Co., Ltd.

US$40.00-65.00

2 Pieces

Product specifications

Type

Sample price:US$55.00/piece.Request sample

Product profile

Customization

Available

Certification

MSDS, GMP, CE

Age Group

Adults

Form

Gel

Transport Package

Single Item

Specification

0.300 kg

Trademark

Rveiling®

Origin

China

Production Capacity

50000PCS/Year

Key features

Permanent Fat Reduction: Disrupts fat cell membranes for permanent elimination via lymphatic system.

Non-Surgical Therapy: Injectable solution for localized fat contouring without surgical intervention.

High Efficacy Rate: Clinically validated to achieve 86% efficacy rate for submental fat accumulation.

Skin Firming Effect: Stimulates collagen regeneration to restore skin elasticity and firmness.

Rapid Metabolism: Ingredient fully degrades and exits body within 24 hours post-injection.

Multiple Treatment Areas: Effective for double chin, arms, abdomen, thighs, and other localized fat.

Sterile & Safe: Synthetic compound eliminating infection risks from human or animal pathogens.

OEM/ODM Support: Multiple packaging formats and scalable order volumes available.

Company profile

Hangzhou Yanfeng Technology Co., Ltd.

Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2023-07-12Nearest Port: shanghai, ningboAverage Response Time: ≤5.44hTerms of Payment: T/T, PayPal, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryHangzhou Yanfeng Technology Co., Ltd. is identified as a trading company and limited company offering medical and aesthetic products including hyaluronic acid dermal fillers, PDO threads, needles and syringes, and botulinum toxins. It reports ISO 13485 and GMP certifications, ODM and OEM capabilities, broad customization services, and substantial export activity, with 90% of total sales from exports and self-operated import/export rights. However, it has only three employees, no overseas showroom, agents, branches, or offline trade-show participation, and no SDK availability. After-sales controls are weakly documented: complaint handling and corrective/preventive-action procedures are absent, while supplier approval records lack signatures or dates. Financial information is limited to year labels without performance values. Audit information identifies TUV Rheinland, but the stated evaluation result is 0 and the report period has expired.

CertificationsThe supplier reports ISO 13485 and GMP certifications. A TUV Rheinland audit is identified, but the audit result is stated as 0 and the report validity ended on 2024-07-04, so the slices do not establish current effective certification or audit compliance.

After-Sales capabilityThe supplier has no overseas showroom, overseas agents or branches, and no recorded offline trade-show participation. More importantly, it has no written procedures or records for effective complaint handling or corrective and preventive actions, while its service-capability assessment only has relevant records without a written procedure.

R&D capabilityThe supplier launched new products during the previous year, provides ODM services, and reports 11–20 years of total R&D-engineer experience. However, no SDK is available, so the evidence supports product-development capability but not SDK-based development.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, and flexible customization, alongside ODM and OEM services for popular brands. This is direct evidence of broad customization capability.

Product Q&A

Q:What is the mechanism of action for this injection?

Deoxycholic Acid disrupts fat cell membranes, triggering inflammation and fat metabolism. Fat is eliminated via the lymphatic system, achieving permanent reduction.

Q:Which areas can be treated with this product?

It is suitable for localized fat deposits including the double chin, submental area, upper arms, abdomen, and thighs.

Q:Who is the suitable candidate for this treatment?

Adults with localized fat, good skin elasticity, and no significant sagging. Contraindicated for pregnant women, breastfeeding women, and those with heart disease or diabetes.

Q:What is the recommended treatment course?

3 to 5 sessions constitute one course, spaced 15 to 20 days apart. Results typically last 3-5 years or longer after 2-4 sessions.

Q:How long does the ingredient stay in the body?

The deoxycholic acid fully degrades and exits the body within 24 hours post-injection, restoring endogenous levels.

Send Inquiry

*To:

Hangzhou Yanfeng Technology Co., Ltd.

*Content:

0/4000

Supplier replies will be sent to your registered email

Rveiling® Dca-Containing Lipolysis Injection Solution

Product specifications

Type